Recent content by tequilaman69

Sorry to hear about this latest failure. How the Board can't get rid of Weber after failure after failure is beyond me. He gets paid millions of dollars for producing absolutely nothing.

Since I'm so invested in this (still) obviously I've given the Lichter sales a ton of thought. He's the founder and Chairman, he also owns a VC fund that invests in early stage biotechs. He dumped close to 2m shares after the P3 failure which is a terrible look, especially since there hasn't...

Very good points, and the failure in this latest Phase 3 is a real head scratcher. After looking at the latest 13F's (institutional investment) they really "piled on" in the last quarter, so there were many believers they would crush Phase 3. I think what's going to be very important to keep...

Very accurate overview, and I'm hurting because of it $$$ :(:(:(. With that said, don't you think their balance sheet of almost $85m gives them enough working capital to make a go at their other pipeline drugs?

fwiw, actually completely retraced the loss and finished up 2%. Makes no sense but I'll take it.

Some news from Otonomy regarding Otividex enrollment. Obviously not specifically OTO-413 related, but thought I'd share. https://investors.otonomy.com/news-releases/news-release-details/otonomy-completes-patient-enrollment-phase-3-trial-otividexr

Yes, entire markets have been red this month.

Yes, i picked up on that part of the presentation as well, and not needing multiple injections is wonderful.

All valid points my friend and unless someone has some insider knowledge on something negative, I'll continue to chalk it up to overall market weakness.

Make it 81k shares :). Couldn't help but be impressed with Weber at the conference today combined with the market weakness. Could still go lower, but we'll see.

Another investor presentation @ Oppenheimer just concluded. Q/A starts around the 16:00 mark: https://wsw.com/webcast/oppenheimer5/otic/2715615

Actually another reason I like Otonomy is because they are in a pretty strong financial position, especially after the secondary raise in July which was gobbled up in just days. At last check I think they have about $80m to $90m on their balance sheet which would give them at the very least a 2...

Based on a few analyst reports I've seen, I see targets in the $9-$11 range, but the market is completely crazy now when good news comes out, so could really gain momentum and additional analyst coverage to hit the $20-$30 range...especially given OTO is dealing in a field where they could be...

I have just over 67K shares with an avg. price of roughly $3.80 per share, so all in all about $254K invested. To be honest, I got into it initially as a chart play when it was in the mid 4's a few months ago, as the chart looked great. As I researched more into the company and the price...

Couldn't agree more, hence why I'm in so heavy on them from an investment standpoint.